Industry Reports Layout

Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.
Market Research Report

Global Biologics Drug Discovery Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

Published On : 2017-09-06 Report Page : 302 Category:Healthcare

Global Biologics Drug Discovery Market Outlook

Market Overview

The drug discovery process comprises of iterative cycles between chemistry and biology. Natural sources serve as compound of interest in drug discovery for the treatment of many diseases. Over 20 new drugs were launched in the market between 2000-2005, originated from terrestrial plants, terrestrial microorganisms, marine organisms and terrestrial vertebrates and invertebrates.

The drug discovery procedure is long, arduous and costly, which has encouraged outsourcing in the drug discovery field. The drug discovery market is driven by the factors such as rising geriatric population, increase in investments in this field due to the advancements in the field of biotechnology, microbiology, genetics and structural biology. However, slow pace of formulating the drug discovery projects by the government hinders the biologics drug discovery market.

For instance, the main purpose of Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection is to supply the Novartis drug discovery pipeline with hit to lead drugs/compounds for present and future portfolios of drug discovery programs. There are many drug discovery approaches targeting the cancerous cells by Novartis Institutes for Biomedical Research, Switzerland and Cambridge.      

Market Segmentation

  • By Technology
  • Q-PCR
  • DNA Microarrays
  • Protein Microarrays
  • High-throughput screening
  • Mass Spectrometry
  • Gel Electrophoresis
  • Chromatography
  • Protein and Nucleic Acid Isolation
  • Other technologies
  • By End User
  • Outsourcing (Contract Research Organization)
  • Insourcing (Within the Organization)
  • By Geography
  • North America (US, Canada) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Rest of the World{Market Share (%), Market Size (USD Billion), Production (Units)}

Growth Drivers and Challenges

The major driving factors of biologics drug discovery market are high prevalence of genetic disorders, nervous system disorders, diabetes and cardiovascular diseases along with advancement in the field of biotechnology, genetics, structural biology and molecular biology. Increase in health expenditure, highly robust, upsurge in the discovery of therapeutics ventures and populated drug pipeline for novel drugs. Furthermore, patents of drugs expire that tends to make the lucrative market for the existing players. In US and Canada biologics drug discovery market is high due to promising healthy potential returns on investments and high-income population.

However, shift from traditional methods to personalized drug discovery is hindering the global biologics drug discovery market. Delay in government approval for drug discovery and huge investment favoring the shift from market branded drugs to generic drugs are the challenges faced by biologics drug discovery market. Lower profit margins of pharmaceutical companies which are due to the huge investments made on drug discovery and consume time hampers the biologics drug discovery market.

Market Size and Forecast

The global market for biologics drug discovery market reached nearly USD 56.6 billion in 2016 and is expected to reach USD 140.9 billion by 2024 at the CAGR of 12% over the forecast period. High throughput screening is widely adopted drug discovery technology owing to the fact that it enables portfolio construction of biologically relevant compounds quickly. The global biologics drug discovery market North America holds the largest market share in the global drug discovery market owing to the concentration of world’s leading pharmaceutical companies. The US and Canadian Government have formulated encouraging policies for the investors to research and develop new drugs.

Key Market Players

  • Johnson and Johnson

o Synopsis

o Business Strategy

o Product Portfolio

o SWOT Analysis

  • Bayer AG
  • Sanofi
  • Novartis
  • AstraZeneca PLC
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Boehringer Ingelheim Inc.
  • Glaxosmithkline LLC
  • Eli Lily
  • Roche Holding AG.
  • Infosys
  • Charles River Laboratories
  • Albany Molecular Research Inc.
  • Boehringer Ingelheim GmBh
  • Covance
  • Jubilant Biosys

Scope Background

Market Synopsis

Market Segmentation

Global biologics drug discovery market is segmented as follows:

  • By  Technology (Market Size, Demand Analysis and Growth Analysis)
  • By  End User (Market Size, Demand Analysis and Growth Analysis)

Global Biologics Drug Discovery Market Report covered insights of below mentioned regions:

  • North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
  • Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
  • Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
  • Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
  • Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
  • Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

Key Market Players

  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks


A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements



A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements